Form D · Other Health Care
Bardy Diagnostics, Inc.
Seattle, WA · CIK 0001686365
Offering snapshot reported Mar 31, 2020 · SEC filing
- Reported sold
- $0 Offering amount: $450K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 18, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 31, 2020 | Initial | $0 | No comparison | 1 | SEC filing |
| Feb 28, 2020 | Initial | $12,492,818 | No comparison | 28 | SEC filing |
| Apr 25, 2019 | Initial | $35,534,146 | No comparison | 25 | SEC filing |
| Jan 3, 2019 | Initial | $6,000,000 | No comparison | 10 | SEC filing |
| Jun 8, 2018 | Amendment | $35,363,985 | $7,750,018vs Oct 12, 2016 | 13 | SEC filing |
| Oct 12, 2016 | Initial | $27,613,967 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-364048
The total offering amount reflects the value of warrants issued. Any proceeds will be realized upon the exercise of such warrants.
Source: Form D, filed Mar 31, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gust H. Bardy | Director, Executive, Promoter |
| Mark Handfelt | Executive, Promoter |
| Jon P. Hunt | Director, Executive, Promoter |
| Garheng Kong | Director |
| Paul La Violette | Director |
| Alan Levy | Director |
| Kevin Nelson, Iii | Executive |
| Mark Querry | Executive |
| David Tamburri | Director |
| Rik Vandevenne | Director |
| Ed Vertatschitsch | Executive |
| Warren Watson | Director |
| Patrick Wethington | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
316 Occidental Avenue South Suite B310
Seattle, WA, 98104
Seattle, WA, 98104